BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 36564811)

  • 21. Safety of fertility sparing management in invasive mucinous ovarian carcinoma.
    Kim SR; Madariaga A; Hogen L; Vicus D; Covens A; Parra-Herran C; Lheureux S; Gien LT
    Gynecol Oncol; 2023 Jul; 174():129-132. PubMed ID: 37182433
    [TBL] [Abstract][Full Text] [Related]  

  • 22. All-Cause Mortality After Fertility-Sparing Surgery for Stage I Epithelial Ovarian Cancer.
    Melamed A; Rizzo AE; Nitecki R; Gockley AA; Bregar AJ; Schorge JO; Del Carmen MG; Rauh-Hain JA
    Obstet Gynecol; 2017 Jul; 130(1):71-79. PubMed ID: 28594773
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Outcomes of fertility-sparing surgery for women of reproductive age with FIGO stage IC epithelial ovarian cancer.
    Kashima K; Yahata T; Fujita K; Tanaka K
    Int J Gynaecol Obstet; 2013 Apr; 121(1):53-5. PubMed ID: 23352733
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The feasibility of fertility-sparing surgery in treating advanced-stage borderline ovarian tumors: A meta-analysis.
    Huang Y; Zhang W; Wang Y
    Taiwan J Obstet Gynecol; 2016 Jun; 55(3):319-25. PubMed ID: 27343308
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pregnancy and oncologic outcomes of early stage low grade epithelial ovarian cancer after fertility sparing surgery: a retrospective study in one tertiary hospital of China.
    Yin J; Wang Y; Shan Y; Li Y; Jin Y; Pan L
    J Ovarian Res; 2019 May; 12(1):44. PubMed ID: 31088507
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recurrence-predicting prognostic factors for patients with early-stage epithelial ovarian cancer undergoing fertility-sparing surgery: a multi-institutional study.
    Kajiyama H; Mizuno M; Shibata K; Yamamoto E; Kawai M; Nagasaka T; Kikkawa F
    Eur J Obstet Gynecol Reprod Biol; 2014 Apr; 175():97-102. PubMed ID: 24507757
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term follow-up of patients with an isolated ovarian recurrence after conservative treatment of epithelial ovarian cancer: review of the results of an international multicenter study comprising 545 patients.
    Bentivegna E; Fruscio R; Roussin S; Ceppi L; Satoh T; Kajiyama H; Uzan C; Colombo N; Gouy S; Morice P
    Fertil Steril; 2015 Nov; 104(5):1319-24. PubMed ID: 26149354
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fertility sparing surgery vs radical surgery for epithelial ovarian cancer: a meta-analysis of overall survival and disease-free survival.
    Liu D; Cai J; Gao A; Wang Z; Cai L
    BMC Cancer; 2020 Apr; 20(1):320. PubMed ID: 32293358
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A retrospective study of 27 ovarian tumors of low malignant potential.
    Demeter A; Csapó Z; Szánthó A; Bálega J; Sipos N; Papp Z
    Eur J Gynaecol Oncol; 2002; 23(5):415-8. PubMed ID: 12440814
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fertility sparing surgery for patients with FIGO stage I clear cell ovarian carcinoma: a database analysis and systematic review of the literature.
    Nasioudis D; Mulugeta-Gordon L; McMinn E; Frey MK; Chapman-Davis E; Holcomb K
    Int J Gynecol Cancer; 2020 Sep; 30(9):1372-1377. PubMed ID: 32847998
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Outcomes of fertility-sparing surgery for invasive epithelial ovarian cancer: oncologic safety and reproductive outcomes.
    Park JY; Kim DY; Suh DS; Kim JH; Kim YM; Kim YT; Nam JH
    Gynecol Oncol; 2008 Sep; 110(3):345-53. PubMed ID: 18586310
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Outcomes after fertility-sparing surgery of early-stage ovarian cancer: A nationwide population-based study.
    Lee CY; Chiang CJ; Tai YJ; Hsu HC; Chen YL; Chiang YC; Wu CY; Lee WC; Hwa HL; Cheng WF
    Cancer Med; 2024 Apr; 13(7):e7132. PubMed ID: 38606892
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fertility-sparing surgery for young patients with borderline ovarian tumors (BOTs): single institution experience.
    Chen RF; Li J; Zhu TT; Yu HL; Lu X
    J Ovarian Res; 2016 Mar; 9():16. PubMed ID: 26988551
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of oncologic and reproductive outcomes after fertility-sparing surgery in apparent stage I adult ovarian granulosa cell tumors.
    Wang D; Cao D; Jia C; Huang H; Yang J; Wu M; Pan L; Shen K; Xiang Y
    Gynecol Oncol; 2018 Nov; 151(2):275-281. PubMed ID: 30219238
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oncofertility outcomes after fertility-sparing treatment of bilateral serous borderline ovarian tumors: results of a large retrospective study.
    Jia SZ; Xiang Y; Yang JJ; Shi JH; Jia CW; Leng JH
    Hum Reprod; 2020 Feb; 35(2):328-339. PubMed ID: 32048711
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Conservative treatment in epithelial ovarian cancer: results of a multicentre study of the GCCLCC (Groupe des Chirurgiens de Centre de Lutte Contre le Cancer) and SFOG (Société Francaise d'Oncologie Gynécologique).
    Morice P; Leblanc E; Rey A; Baron M; Querleu D; Blanchot J; Duvillard P; Lhommé C; Castaigne D; Classe JM; Bonnier P;
    Hum Reprod; 2005 May; 20(5):1379-85. PubMed ID: 15817592
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Outcomes of fertility-sparing surgery among young women with FIGO stage I clear cell carcinoma of the ovary.
    Park JY; Suh DS; Kim JH; Kim YM; Kim YT; Nam JH
    Int J Gynaecol Obstet; 2016 Jul; 134(1):49-52. PubMed ID: 27039052
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Conservative surgery in ovarian borderline tumours: a meta-analysis with emphasis on recurrence risk.
    Vasconcelos I; de Sousa Mendes M
    Eur J Cancer; 2015 Mar; 51(5):620-31. PubMed ID: 25661104
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fertility-sparing surgery for young women with early-stage epithelial ovarian cancer.
    Nam JH; Park JY
    Gynecol Obstet Invest; 2013; 76(1):14-24. PubMed ID: 23751891
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical outcomes of fertility-sparing treatments in young patients with epithelial ovarian carcinoma.
    Hu J; Zhu LR; Liang ZQ; Meng YG; Guo HY; Qu PP; Ma CL; Xu CJ; Yuan BB
    J Zhejiang Univ Sci B; 2011 Oct; 12(10):787-95. PubMed ID: 21960341
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.